Branded Pharma And Generics Industries At Odds Over UK VPAG Framework

 
• By Eliza Slawther and Dave Wallace
  
The UK branded drug and generics industries have different views on rebate rates under the VPAG scheme (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Government Payers

More from Market Access